Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae Mycelia
NCT04063735 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97
Last updated 2019-08-21
Summary
Cordyceps cicadae mycelia was tested for amelioration of dry eye symptoms through dietary supplementation. Its efficacy in relief of human dry eye status was assessed by randomized, double-blinded tests, including multiple assessments. The results were compared between the placebo group and the experimental group.
Conditions
- Dry Eye
- Supplement
Interventions
- DIETARY_SUPPLEMENT
-
Cordyceps Cicadae Mycelia
Cordyceps Cicadae Mycelia supplement for 3 months
- DIETARY_SUPPLEMENT
-
Placebo
Placebo was given to participants.
Sponsors & Collaborators
-
Grape King Bio Ltd.
collaborator INDUSTRY -
David Pei-Cheng Lin
lead OTHER
Principal Investigators
-
David Pei-Cheng Lin, PhD · Chung Shan Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-01
- Primary Completion
- 2017-02-07
- Completion
- 2017-11-30
More Related Trials
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00403715 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
NCT04362670 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes
NCT06898853 ·Status: RECRUITING ·Phase: NA
-
Acupuncture for Dry Eye Syndrome
NCT00969280 ·Status: COMPLETED ·Phase: PHASE3
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RX-10045 in the Treatment of Dry Eye Disease
NCT01675570 ·Status: COMPLETED ·Phase: PHASE2
-
Potential Role of Ocular Surface Microbiome in Dry Eye: Microbial Interactions and Symptom Alleviation
NCT06936462 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
NCT06766357 ·Status: RECRUITING ·Phase: PHASE3
-
Dry Eye Symptom Mitigation by Oral Intake of Probiotics
NCT05906381 ·Status: COMPLETED ·Phase: NA
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Mask-associated Dry Eye Symptoms in China
NCT04744805 ·Status: UNKNOWN
-
Efficacy of Twinkle Eyez Supplementation in Improving Ocular Health and Immunity
NCT06574685 ·Status: COMPLETED ·Phase: NA
-
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients
NCT01250171 ·Status: COMPLETED ·Phase: PHASE2
-
Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
NCT03617315 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis
NCT05733624 ·Status: COMPLETED ·Phase: PHASE2
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Evaluate the Efficacy and Safety of CKD-352
NCT04548427 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome
NCT00357201 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
NCT03237936 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD
NCT04213248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
NCT00739349 ·Status: COMPLETED ·Phase: PHASE2